About
Enedra Therapeutics uses an AI-driven platform to identify conserved genetic signatures in heterogeneous tumors and develops targeted cancer therapies to overcome drug resistance caused by tumor genomic heterogeneity.
Explore Enedra Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.